医学
银屑病
氯沙坦
中止
病因学
非甾体
药品
疾病
不利影响
皮肤病科
发病机制
内科学
药理学
血管紧张素II
血压
作者
Gurpreet Lamba,Chandrasekar Palaniswamy,Tarunjit Singh,Dhaval K. Shah,Sonia Lal,Ravi Vinnakota,Elliott J Charrow,Leanne Forman
出处
期刊:American Journal of Therapeutics
日期:2010-03-24
卷期号:18 (3): e78-e80
被引量:23
标识
DOI:10.1097/mjt.0b013e3181c6c0c2
摘要
Psoriasis is a papulosquamous disease of multifactorial etiology. A combination of genetic and environmental agents is implicated in its pathogenesis. A variety of triggers, including infection, stress, and medications, have been recognized as precipitants of this disease. Nonsteroidal anti-inflammatory drugs, beta-blockers, lithium, synthetic antimalarials, and gold are the most common drugs implicated in precipitating psoriasis. We report a patient with psoriasis induced by initiation of losartan therapy, which resolved with discontinuation of the drug. The Naranjo adverse drug reaction probability scale score indicated that the association between losartan use and psoriasis was probable.
科研通智能强力驱动
Strongly Powered by AbleSci AI